Category Specific RSS

News

International payments processor Novatti grows revenue by 45%

Fintech developer and transactions processor Novatti (ASX: NOV) has reported record payment processing revenues for the quarter ending December 31, 2019, a rise of 45% compared to the corresponding 2018 quarter.

The increase from $1.15m to $1.55m comes solely from Novatti’s international transaction processing business, just one division of the Company which has a banking licence application pending and expected to be granted in early 2020. 

“Growing Novatti’s core transaction processing business remains a key focus for our team and we expect strong revenue growth to continue here in FY20,” said Novatti CEO, Peter Cook. 

“From a strategic point of view, this is welcomed, as we believe many of Novatti’s existing transaction processing customers will be primary customers for future banking services, aiding broader growth for the company.”

The significant growth in their payment processing business continues a strong 6 months for Novatti which last week reported that strategic investors had committed $18m in their banking service subsidiary, enabling the Novatti to meet the Tier 1 capital requirements for the licence and working capital without any further funding required. 

Upon granting of the licence, Novatti intends to launch a digital banking service which will target migrant populations and leverage existing fintech infrastructure Novatti has developed. 

With its growth in payment processing revenue, the Company has reported consecutive cash flow positive quarters in Q419 and Q120. Novatti is expected to release Q220 figures next week. 

Novatti invites investors to keep up to date with company news, events and industry research by joining the Novatti mailing list at: https://www.novattigroup.com/subscribe


*Owners of this website are shareholders in a company mentioned in this article and have been engaged by them to assist in investor communications

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago